Company: ENTXW
Filing Date: 2025-06-05
Form Type: DEF 14A
Source: 0001178913-25-002111
Chunk: 84

Company: Entera Bio Ltd.
Filing Date: 2025-06-05
Form: DEF 14A
Chunk 84
---
 | Variable performance-based awards (e.g. annual bonus)- designed to reward the Office Holder                                                       
 for his or her achievements and contribution to attaining the Company's goals during the course of the period for which the variable compensation 
 is paid and to supplement the base salary. The weight of variable performance-based compensation in relation to the overall compensation          
 shall increase the higher the Officer’s position is.                                                                                              |

| • | Equity-based compensation- designed to link long-term shareholder returns and the compensation                                           
 of Office Holders of the Company. Equity- based compensation creates a correlation between the interests of employees and Office Holders 
 and the interests of the  Company’s shareholders, and assists in creating motivation and in retaining the key personnel in               
 the Company.                                                                                                                             |

| 6.2. | Ratio Between Variable and Fixed Components of the Compensation Package |

The rate of the annual variable components (including, without limitation, cash bonuses, performance-based awards and equity-based awards) of the Office Holders overall annual compensation package (comprised of the base salary and variable components) shall not exceed the 80% of the Office Holder's total compensation package. A deviation of up to 10% of these terms shall not constitute a deviation or deflection from the compensation policy. Note that this refers to the planned ratio only, assuming the receipt of the target bonus as stated in this policy. The actual ratio between the components of the compensation package, in a given year, may be different due to underperformance or overachievement impacting the variable compensation, as stated in this Policy.

| 6.3. | Market comparison (benchmark) |

To determine the salary for the recruitment of our new Office Holders, a comparison shall be made of the acceptable salary in the market for similar positions in companies similar to the Company (“ Peer Group”). For purposes of the foregoing comparative studies, companies meeting the following characteristics shall be selected:

| • | Companies operating in the field of biotech, pharmaceutical, drug development or other related fields; |

| • | Israeli companies whose shares are traded on the NASDAQ Stock Market or NYSE to the extent practicable, based in Israel, and preferably, 
 with officers residing in the US;if the number of such companies is lower than 10, the Peer Group may                                    
 also include US companies; and                                                                                                           |

| • | Companies of similar size in the following financial dimensions: market cap, shareholder equity, balance sheet, sales turnover, operating 
 profit and/or net profit, as provided in the most updated